Molecular epidemiology, pathogenesis and prevention of gastric cancer

Carcinogenesis

Volumn 20, Issue 12, 1999, Pages 2195-2207

  Stadtländer, Christian T K H ^a   Waterbor, John W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PROTEIN P53; UVOMORULIN;

ASIA; CANCER GENETICS; CANCER MORTALITY; CANCER PREVENTION; CHROMOSOMAL LOCALIZATION; DIET; GENE LOCATION; GENETIC EPIDEMIOLOGY; HEREDITY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE C ERB; ONCOGENE C MYC; ONCOGENE K RAS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE; UNITED STATES;

EID: 0342514585     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.12.2195     Document Type: Review

References (139)

1. Parkin, D.M., Läärä, E. and Muir, C.S. (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41, 184-197.
2. Parkin, D.M., Pisani, P. and Ferlay, J. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606.
3. Howson, C.P., Hiyama, T. and Wynder, E.L. (1986) The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev., 8, 1-27.
4. Kramer, B.S. and Johnson, K.A. (1995) Other gastrointestinal cancers: stomach, liver. In Greenwald, P., Kramer, B.S. and Weed, D.L. (eds) Cancer Prevention and Control. Marcel Dekker, New York, NY, pp. 673-694.
5. O'Connor, F., Buckley, M. and O'Morain, C. (1996) Helicobacter pylori: the cancer link. J. R. Soc. Med., 88, 674-678.
6. Cover, T.L. and Blaser, M.J. (1995) Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. Am. Soc. Microbiol. News, 61, 21-26.
7. Watanabe, S., Tsugane, S. and Yamaguchi, N. (1997) Etiology. In Sugimura, T. and Sasako, M. (eds) Gastric Cancer. Oxford University Press, Oxford, UK, pp. 33-51.
8. Ochiai, A. and Hirohashi, S. (1997) Multiple genetic alterations in gastric cancer. In Sugimura, T. and Sasako, M. (eds) Gastric Cancer. Oxford University Press, Oxford, UK, pp. 87-99.
9. Levin, D.L., Devesa, S.S., Godwin, J.D. and Silverman, D.T. (1974) Cancer Rates and Risks. DHEW Publication no. (NIH) 75-691, US Government Printing Office, Washington, DC.
10. Haenszel, W. (1958) Variation in incidence of and mortality from stomach cancer, with particular reference to the United States. J. Natl Cancer Inst., 21, 213-262.
11. Cutler, S.J., Scotto, J., Devesa, S.S. and Connelly, R.R. (1974) Third national cancer survey - an overview of available information. J. Natl Cancer Inst., 53, 1565-1575.
12. Ries, L.A.G., Kosary, C.L., Hankey, B.F., Miller, B.A. and Edwards, B.K. (1999) SEER Cancer Statistics Review, 1973-1996. National Cancer Institute, Bethesda, MD.
13. Coleman, M.P., Estève, J., Damiecki, P., Arslan, A. and Renard, H. (1993) Trends in Cancer Incidence and Mortality. IARC Scientific Publications no. 121, IARC, Lyon.
14. Zatonski, W., Smans, M., Tyczynski, J. and Boyle, P. (1996) Atlas of Cancer Mortality in Central Europe. IARC Scientific Publications no. 134, IARC, Lyon.
15. Black, R.J., Bray, F., Ferlay, J. and Parkin, D.M. (1997) Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur. J. Cancer, 33, 1075-1107.
16. Møller Jensen, O., Carstensen, B., Glattre, E., Malker, B., Pukkala, E. and Tulinius, H. (1988) Atlas of Cancer Incidence in the Nordic Countries. Nordic Cancer Union, Helsinki, Finland.
17. Hansson, L.E., Sparen, P. and Nyrén, O. (1993) Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br. J. Surg., 80, 374-377.
18. Ekström, A.M., Signorello, L.B., Hansson, L.E., Bergström, R., Lindgren, A. and Nyrén, O. (1999) Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J. Natl Cancer Inst., 91, 786-790.
19. Berrino, F., Sant, M., Verdecchia, A., Capocaccia, R., Hakulinen, T. and Estève, J. (1995) Survival of Cancer Patients in Europe - the EUROCARE Study. IARC Scientific Publications no. 132, IARC, Lyon.
20. Muir, C.S. and Harvey, J.C. (1997) Cancer of the stomach: overview. In Sugimura, T. and Sasako, M. (eds) Gastric Cancer. Oxford University Press, Oxford, UK, pp. 3-21.
21. Kuroishi, T., Hayakawa, N., Kurihara, M. and Aoki, K. (1994) Cancer mortality in 33 countries of the world (1953-1987). In Tominaga, S., Aoki, K., Fujimoto, I. and Kurihara, M. (eds) Cancer Mortality and Morbidity Statistics, Gann Monographs on Cancer Research no. 41. CRC Press, Boca Raton, FL, pp. 167-230.
22. Correa, P. (1992) Human gastric carcinogenesis: a multistep and multifactorial process - first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res., 52, 6735-6740.
23. Haenszel, W. and Kurihara, M. (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst., 40, 43-68.
24. Buell, P. and Dunn, J.E.Jr (1965) Cancer mortality among Japanese Issei and Nisei of California. Cancer, 18, 656-664.
25. Hermanek, P. and Wittekind, C. (1995) News of TNM and its use for classification of gastric cancer. World J. Surg., 19, 491-495.
26. Laurén, R. (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histoclinical classification. Acta Pathol. Microbiol. Scand., 64, 31-49.
27. Hotz, J. and Goebell, H. (1989) Epidemiology and pathogenesis of gastric carcinoma. In Hotz, J., Meyer, H.-J. and Schmoll, H.-J. (eds) Gastric Carcinoma - Classification, Diagnosis, and Therapy. Springer-Verlag, New York, NY, pp. 3-15.
28. Muñoz, N., Correa, P., Cuello, C. and Duque, E. (1968) Histologic types of gastric carcinoma in high and low risk areas. Int. J. Cancer, 3, 809-818.
29. Neugut, A.I., Hayek, M. and Howe, G. (1996) Epidemiology of gastric cancer. Semin. Oncol., 23, 281-291.
30. Muñoz, N. and Matko, I. (1972) Histological types of gastric cancer and its relationship with intestinal metaplasia. Cancer Res., 39, 99-105.
31. Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S. and Archer, M. (1975) A model for gastric cancer epidemiology. Lancet, ii, 58-60.
32. Correa, P. (1988) A human model of gastric carcinogenesis. Cancer Res., 48, 3554-3560.
33. Nomura, A. (1982) Stomach. In Schottenfeld, D. and Fraumeni, J.F. (eds) Cancer Epidemiology and Prevention. W.B. Saunders, Philadelphia, PA, pp. 624-637.
34. Wright, P.A., Quirke, R. Attanoos, R. and Williams, G.T. (1992) Molecular pathology of gastric carcinoma: progress and prospects. Hum. Pathol., 23, 848-859.
35. Tahara, E. (1995) Molecular biology of gastric cancer. World J. Surg., 19, 484-488.
36. Hesketh, R. (1997) The Oncogene and Tumour Suppressor Gene Facts Book. Academic Press, San Diego, CA.
37. Wu, M.S., Shun, C.T., Wang, H.P., Sheu, J.C., Lee, W.J., Wang, T.H. and Lin, J.T. (1997) Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology, 112, 1457-1465.
38. Kanai, Y. and Hirohashi, S. (1997) Invasion and metastasis. In Sugimura, T. and Sasako, M. (eds) Gastric Cancer. Oxford University Press, Oxford, UK, pp. 109-123.
39. Drasar, B.S., Shiner, M. and McLeod, G.M. (1969) Studies on the intestinal flora: I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology, 56, 71-79.
40. Hill, M.J. (1986) Microbes and Human Carcinogenesis. Edward Arnold, London, UK.
41. Marshall, B.J. and Warren, J.R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, i, 1311-1314.
42. Marshall, B.J., Royce, H., Annear, D.I., Goodwin, C.S., Pearman, J.W., Warren, J.R. and Armstrong, J.A. (1984) Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios. Lett., 25, 83-88.
43. Marshall, B.J. and Goodwin, C.S. (1987) Revised nomenclature of Campylobacter pyloridis. Int. J. Syst. Bacteriol., 37, 68.
44. Goodwin, C.S., Armstrong, J.A., Chilvers, T., Peters, M., Collins, M.D., Sly, L., McConnell, W. and Harper, W.E.S. (1989) Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively, Int. J. Syst. Bacteriol., 39, 397-405.
45. Hazell, S.L. and Mendz, G.L. (1993) The metabolism and enzymes of Helicobacter pylori: function and potential virulence effects. In Goodwin, C.S. and Worsley, B.W. (eds) Helicobacter pylori - Biology and Clinical Practice. CRC Press, Boca Raton, FL, pp. 115-141.
46. Blaser, M.J., Perez-Perez, G.I., Kleanthous, H., Cover, T.L., Peek, R.M., Chyou, P.H., Stemmermann, G.N. and Nomura, A. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res., 55, 2111-2115.
47. Censini, S., Lange, C., Xiang, Z., Crabtree, J.E., Ghiara, P., Borodovsky, M., Rappuoli, R. and Covacci, A. (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type 1-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA, 93, 14648-14653.
48. Atherton, J.C. (1998) H.pylori virulence factors. Br. Med. Bull., 54, 105-120.
49. Bodger, K. and Crabtree, J.E. (1998) Helicobacter pylori and gastric inflammation. Br. Med. Bull., 54, 139-150.
50. Cahill, R.J., Sant, S., Beattie, S., Hamilton, H. and O'Morain, C. (1994) Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur. J. Gastroenterol. Hepatol., 6, 1123-1127.
51. Blaser, M.J. and Parsonnet, J. (1994) Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest., 94, 4-8.
52. Forman, D. (1998) Helicobacter pylori infection and cancer. Br. Med. Bull., 54, 71-78.
53. Correa, P. and Miller, M.J.S. (1998) Carcinogenesis, apoptosis and cell proliferation. Br. Med. Bull., 54, 151-162.
54. Farthing, M.J.G. (1998) Helicobacter pylori infection: an overview. Br. Med. Bull., 54, 1-6.
55. Pisani, P., Maxwell Parkin, D., Muñoz, N. and Ferlay, J. (1997) Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomarkers Prev., 6, 387-400.
56. Parsonnet, J. (1998) Helicobacter pylori. Infect. Dis. Clin. North Am., 12, 185-197.
57. Wotherspoon, A.C (1998) Helicobacter pylori infection and gastric lymphoma. Br Med. Bull., 54, 79-85.
58. Halter, F., Hurlimann, S. and Inauen, W. (1992) Pathophysiology and clinical relevance of Helicobacter pylori. Yale J. Biol. Med., 65, 625-638.
59. Taylor, D.N. and Blaser, M.J. (1991) The epidemiology of Helicobacter pylori infection. Epidemiol. Rev., 13, 42-59.
60. Aromaa, A., Kosunen, T.U., Knekt, P., Maatela, J., Teppo, L., Heinonen, O.P., Harkonen, M. and Hakama, M.K. (1996) Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am. J. Epidemiol., 144, 142-149.
61. Glupczynski, Y. (1998) Microbiological and serological diagnostic tests for Helicobacter pylori: an overview. Br. Med. Bull., 54, 175-186.
62. International Agency for Research on Cancer (1994) Infection with Helicobacter pylori. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 61, Schistosomes, Liver Flukes and Helicobacter pylori. IARC, Lyon, pp. 177-240.
63. Parsonnet, J., Friedman, G.D., Vandersteen, D.P. Change, Y., Vogelman, J.H., Orentreich, N. and Sibley, R.K. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325, 1127-1131.
64. McNulty, C.A.M, Dent, J.C., Curry, A., Uff,J.S., Ford, G.A., Gear, M.W.L. and Wilkinson, S.P. (1989) New spiral bacterium in gastric mucosa. J. Clin. Pathol., 42, 585-591.
65. Solnick, J.V., O'Rourke, J., Lee, A., Paster, B.J., Dewhirst, F.E. and Tompkins, L.S. (1993) An uncultured gastric spiral organism is a newly identified helicobacter in humans. J. Infect. Dis., 168, 379-385.
66. Yang, H., Li, X., Xu, Z. and Zhou, D. (1995) 'Helicobacter heilmannii' infection in a patient with gastric cancer. Dig. Dis. Sci., 40, 1013-1014.
67. Morgner, A., Bayerdörffer, E., Meining, A., Stolte, M. and Kroher, G. (1995) Helicobacter heilmannii and gastric cancer. Lancet, 346, 511-512.
68. Stolte, M., Kroher, G., Meining, A., Morgner, A., Bayerdörffer, E. and Bethke, B. (1997) A comparison of Helicobacter pylori and H.heilmannii gastritis. A matched control study involving 404 patients. Scand. J. Gastroenterol., 32, 28-33.
69. Regimbeau, C., Karsenti, D., Durand, V., D'Alteroche, L., Copie-Bergman, C., Metman, E.H. and Machet, M.C. (1998) Low-grade gastric MALT lymphoma and Helicobacter heilmannii. Gastroenterol. Clin. Biol., 22, 720-723.
70. Hilzenrat, N., Lamoureux, E., Weintrub, I., Alpert, E., Lichter, M. and Alpert, L. (1995) Helicobacter heilmannii-like spiral bacteria in gastric mucosal biopsies. Prevalence and clinical significance. Arch. Pathol. Lab. Med., 119, 1149-1153.
71. Sasaki, H., Igaki, H., Ishizuka,T., Kogoma, Y., Sugimura, T. and Terada, M. (1995) Presence of Streptococcus DNA sequence in surgical specimens of gastric cancer. Jpn J. Cancer Res., 86, 791-794.
72. Sipponen, P. and Stolte, M. (1997) Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy, 29, 671-678.
73. Epstein, M.A., Achong, B.G. and Barr, Y.M. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, i, 702-703.
74. International Agency for Research on Cancer (1997) Epstein-Barr virus. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 70, Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. IARC, Lyon, pp. 47-373.
75. Oda, K., Tamaru, J., Takenouchi, T., Mikata, A., Nunomura, M., Saitoh, N., Sarashina, H. and Nakajima, N. (1993) Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol., 143, 1063-1071.
76. Tokunaga, M., Land, C.E., Uemura, Y., Tokudome, T., Tanaka, S. and Sato, E. (1993) Epstein-Barr virus in gastric carcinoma. Am. J. Pathol., 143, 1250-1254.
77. Fukayama, M., Hayashi, Y., Iwasaki, Y., Chong, J., Ooba, T., Takizawa, T., Koike, M., Mizutani, S. and Hirai, K. (1994) Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest., 71, 73-81.
78. Yuen, S.T., Chung, L.P., Leung, S.Y., Luk, I.S., Chan, S.Y. and Ho, J. (1994) In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am. J. Surg. Pathol., 18, 1158-1163.
79. Wang, M., Tokunaga, M. and Jia, X.S. (1994) Observations on the relation of gastric carcinoma to Epstein-Barr virus. Chin. J. Pathol., 23, 285-287.
80. Harn, H.J., Chang, J.Y., Wang, M.W., Ho, L.I., Chiang, J.H. and Lee, W.H. (1995) Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum. Pathol., 26, 267-271.
81. Shin, W.S., Kang, M.W., Kang, J.H., Choi, M.K., Ahn, B.M., Kim, J.K., Sun, H.S. and Min, K.W. (1996) Epstein-Barr virus-associated gastric adenocarcinomas among Koreans. Am. J. Clin. Pathol., 105, 174-181.
82. Ott, G., Ott, M.M., Feller, A.C., Seidl, S. and Muller-Hermelink, H.K. (1992) Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int. J. Cancer. 51, 562-567.
83. Selves, J., Bibeau, F., Brousset, P., Meggetto, F., Mazerolles, C., Voigt, J.J., Pradere, B., Chiotasso, P. and Delsol, G. (1996) Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathol., 28, 121-127.
84. Gulley, M.L., Pulitzer, D.R., Eagan, P.A. and Schneider, B.G. (1996) Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum. Pathol., 27, 20-27.
85. Blasco, J., Guido, M., Carestia, M., Power, C., Drut, M. and Drut, R. (1996) Undifferentiated gastric carcinoma of lymphoepithelioma type with Epstein-Barr virus. Medicina, 56, 287-290.
86. Shibata, D. and Weiss, L.M. (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol., 140, 769-774.
87. Ojima, H., Fukuda, T., Nakajima, T. and Nagamachi, Y. (1997) Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J. Cancer Res., 88, 262-266.
88. Wu, C.S., Wu, S.S. and Chen, P.C. (1995) A prospective study of fungal infection of gastric ulcers: clinical significance and correlation with medical treatment. Gastrointest. Endosc., 42, 56-58.
89. Kimura, M., Udagawa, S., Toyazaki, N., Iimori, M. and Hashimoto, S. (1995) Isolation of Rhizopus microsporus var. rhizopodiformis in the ulcer of human gastric carcinoma. J. Med. Vet. Mycol., 33, 137-139.
90. van Thiel, P.H. (1960) A nematode parasitic to herring causing acute ahdominal syndromes in man. Trop. Geogr. Med., 2, 97-113.
91. Sugimachi, K., Inokuchi, K., Ooiwa, T., Fujino, T. and Ishii, Y. (1985) Acute gastric anisakiasis - analysis of 178 cases. J. Am. Med. Assoc., 253, 1012-1013.
92. Kakizoe, S., Kakizoe, H., Kakizoe, K., Kakizoe, Y., Maruta, M., Kakizoe, T. and Kakizoe, S. (1995) Endoscopic findings and clinical manifestation of gastric anisakiasis. Am. J. Gastroenterol., 90, 761-763.
93. Petithory, J.C., Paugam, B., Buyet-Rousset, P. and Paugam, A. (1990) Anisakis simplex, a co-factor of gastric cancer? Lancet, 336, 1002.
94. Tamura, G. (1996) Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach. Pathol. Int., 46, 834-841.
95. Takahashi, M. and Hasegawa, R. (1990) Tumours of the stomach. In Turusov, V. and Mohr, U. (eds) Patholagy of Tumours in Laboratory Animals: I. Tumours of the Rat. IARC Scientific Publications no. 99, IARC, Lyon, pp. 129-157.
96. Takahashi, M. and Okamiya, H. (1996) Tumours of the glandular stomach. In Turusov, V. and Mohr, U. (eds) Pathology of Tumours in Laboratory Animals: III. Tumours of the Hamster. IARC Scientific Publications no. 126, IARC, Lyon, pp. 127-135.
97. Ohgaki, H. and Sugimura, T. (1997) Experimental gastric cancer. In Sugimura, T. and Sasako, M. (eds) Gastric Cancer. Oxford University Press, Oxford, UK, pp. 73-86.
98. Kawasaki, H., Morishige, F., Tanaka, H. and Kimoto, E. (1982) Influence of oral supplementation of ascorbate upon the induction of N-methyl-N′-nitro-A-nitrosoguanidine. Cancer Lett., 16, 57-63.
99. Kobayashi, M., Kogata, M., Yamamura, M., Takada, H., Hioki, K. and Yamamoto, M. (1986) Inhibitory effect of dietary selenium on carcinogenesis in rat glandular stomach induced by N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res., 46, 2266-2270.
100. Santamaria, C., Bianci, A., Ravetto, C., Arnaboldi, A., Santogati, G. and Andreoni, L. (1987) Prevention of gastric cancer induced by MNNG in rats fed supplemental carotenoids. J. Nutr. Growth Cancer, 4, 175-181.
101. Nishikawa, A., Furukawa, F., Mitsui, M., Enami, T., Kawanishi, T., Hasegawa, T. and Takahashi, M. (1992) Inhibitory effect of calcium chloride on gastric carcinogenesis in rats after treatment with N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Carcinogenesis, 13, 1155-1158.
102. Drake, I.M., Davies, M.J., Mapstone, N.P., Dixon, M.F., Schorah, C.J., White, K.L., Chalmers, D.M. and Axon, A.T. (1996) Ascorbic acid may protect against gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis, 17, 559-562.
103. Arroyo, P.L., Hatch-Pigott, V., Mower, H.F. and Cooney, R.V. (1992) Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res., 281, 193-202.
104. Bertram, J.S., Hossain, M.Z., Pung, A. and Rundhaug, J.E. (1989) Development of in vitro systems for chemoprevention research. Prev. Med., 18, 562-575.
105. Tanaka, H., Hirose, M., Hagiwara, A., Imaida, K., Shirai, T. and Ito, N. (1995) Rat strain differences in catechol carcinogenicity to the stomach. Food Chem. Toxicol., 33, 93-98.
106. Li, Q., Aubrey, M.T., Christian, T. and Freed, B.M. (1997) Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam. Appl. Toxicol., 38, 158-165.
107. Schaefer, D., Jürgensmeier, J.M. and Bauer, G. (1995) Catechol interferes with TGF-β-induced elimination of transformed cells by normal cells: implications for the survival of transformed cells during carcinogenesis. Int. J. Cancer, 60, 520-526.
108. Lee, A. (1995) Helicobacter infections in laboratory animals: a model for gastric neoplasias? Ann. Med., 27, 575-582.
109. Lee, A. (1998) Animal models for host-pathogen interaction studies. Br. Med. Bull., 54, 163-173.
110. Shomer, N.H., Dangler, C.A., Whary, M.T. and Fox, J.G. (1998) Experimental Helicobacter pylori infection induces antral gastritis and gastric mucosa-associated lymphoid tissue in guinea pigs. Infect. Immun., 66, 2614-2618.
111. Lee, A., Chen, M.H., Coltro, N., O'Rourke, J., Hazell, S., Hu, P. and Li, Y. (1993) Long-term infection of the gastric mucosa with Helicobacter species does induce atrophic gastritis in an animal model of Helicobacter pylori infection. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis., 280, 38-50.
112. Fox, J.G., Wishnok, J.S., Murphy, J.C., Tannenbaum, S.R. and Correa, P. (1993) MNNG-induced gastric carcinoma in ferrets infected with Helicobacter mustelae. Carcinogenesis, 14, 1957-1961.
113. Handt, L.K., Fox, J.G., Dewhirst, F.E., Fraser, G.J., Paster, B.J., Yan, L.L., Rozmiarek, H. Rufo, R. and Stalis, I.H. (1994) Helicobacter pylori isolated from the domestic cat: public health implications. Infect. Immun., 62, 2367-2374.
114. Hirayama, F., Takagi, S., Yokoyama, Y., Iwao, E. and Ikeda, Y. (1996) Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J. Gastroenterol., 31 (suppl. 9), 24-28.
115. Ikeno, T., Ota, H., Sugiyama, A., Ishida, K., Katsuyama, T., Genta, R.M. and Kawasaki, S. (1999) Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am. J. Pathol., 154, 951-960.
116. Honda, S., Fujioka, T., Tokieda, M., Satoh, R., Nishizono, A. and Nasu, M. (1998) Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res., 58, 4255-4259.
117. Sugiyama, A., Maruta, F., Ikeno, T., Ishida, K., Kawasaki, S., Katsuyama, T., Shimizu, N. and Tatematsu, M. (1998) Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res., 58, 2067-2069.
118. Tatematsu, M., Yamamoto, M., Shimizu, N., Yoshikawa, A., Fukami, H., Kaminishi, M., Oohara, T., Sugiyama, A. and Ikeno, T. (1998) Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine in drinking water. Jpn J. Cancer Res., 89, 97-104.
119. Zhang, H.M., Wakisaka, N., Maeda, O. and Yamamoto, T. (1997) Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer, 80, 1897-1903.
120. Enno, A., O'Rourke, J.L., Howlett, C.R., Jack, A., Dixon, M.F. and Lee, A. (1995) MALToma-like lesions in the murine gastric mucosa after long-term infection with H. felis - a mouse model of Helicobacter pylori-induced gastric lymphoma. Am. J. Pathol., 147, 217-222.
121. Sekiguchi, M., Sakakibara, K. and Fuji, G. (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J. Exp. Med., 48, 61-68.
122. Barranco, S.C., Townsend, C.M.Jr., Casartelli, C., Macik, B.G., Burger, N.L., Boerwinkle, W.R. and Gourley, W.K. (1983) Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res., 43, 1703-1709.
123. Tajima, M., Komura, M. and Okinaga, K. (1998) Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn J. Cancer Res., 89, 262-268.
124. Correa, P. (1986) Diet and gastric cancer. In Reddy, B.S. and Cohen, L.A. (eds) Diet, Nutrition, and Cancer: A Critical Evaluation. Vol. I: Macronutrients and Cancer. CRC Press, Boca Raton, FL, pp. 1-10.
125. Breslow, R.A., Subar, A.F., Patterson, B.H. and Block, G. (1997) Trends in food intake: the 1987 and 1992 National Health Interview Surveys. Nutr. Cancer, 28, 86-92.
126. Pool-Zobel, B.L., Bub, A., Müller, H., Wollowski, I. and Rechkemmer, G. (1997) Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis, 18, 1847-1850.
127. Inoue, M., Tajima, K., Hirose, K., Hamajima, N., Takezaki, T., Kuroishi, T. and Tominaga, S. (1998) Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control, 9, 209-216.
128. Weisburger, J.H., Barnes, W.S. and Czemiak, R. (1986) Mutagens and carcinogens in food. In Reddy, B.S. and Cohen, L.A. (eds) Diet, Nutrition, and Cancer: A Critical Evaluation. Vol. II: Micronutrients, Nonnutritive Dietary Factors, and Cancer. CRC Press, Boca Raton, FL, pp. 115-134.
129. Bartsch, H., Ohshima, H., Pignatelli, B. and Calmels, S. (1992) Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics, 2, 272-277.
130. Wolfsen, H.C. and Talley, N.J. (1993) The diagnosis and treatment of duodenal and gastric ulcer. In Goodwin, C.S. and Worsley, B.W. (eds) Helicobacter pylori - Biology and Clinical Practice. CRC Press, Boca Raton, FL, pp. 365-395.
131. Harris, A. (1998) Current regimens for treatment of Helicobacter pylori infection. Br. Med. Bull., 54, 195-205.
132. Chen, M. and Lee, A. (1993) Vaccination possibilities and probabilities. In Northfield, T.C., Mendall, M. and Goggin, P.M. (eds) Helicobacter pylori Infection - Pathophysiology, Epidemiology and Management. Kluwer Academic, Lancaster, UK, pp. 158-169.
133. Kleanthous, H., Lee, C.K. and Monath, T.P. (1998) Vaccine development against infection with Helicobacter pylori. Br. Med. Bull., 54, 229-241.
134. NIH Consensus Conference (1994) Helicobacter pylori in peptic ulcer disease. J. Am. Med. Assoc., 272, 65-69.
135. Moayyedi, P. and Axon, A.T.R. (1998) Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for. Br. Med. Bull., 54, 243-250.
136. Patchett, S.E. (1998) Helicobacter pylori eradication. Cost-benefit: the case against. Br. Med. Bull., 54, 251-257.
137. Cocco, R., Ward, M.H. and Buiatti, E. (1996) Occupational risk factors for gastric cancer: an overview. Epidemiol. Rev., 18, 218-234.
138. Parent, M.-É., Siemiatycki, J. and Fritschi, L. (1998) Occupational exposures and gastric cancer. Epidemiology, 9, 48-55.
139. Pearce, N. and Matos, E. (1994) Strategies for the prevention of occupational cancer in developing countries. In Pearce, N., Matos, E., Vainio, H., Boffetta, P. and Kogevinas, M. (eds) Occupational Cancer in Developing Countries. IARC Scientific Publications no. 129, IARC, Lyon, pp. 173-183.